🚀 Unlocking #iPSC Innovation: Next-Generation Reprogramming, Engineering & Manufacturing Solutions 🚀 The promise of induced pluripotent stem cells (iPSCs) in disease modeling and #cell_therapy is immense, but technical and scalability challenges remain. #uBriGene_Biosciences is breaking these barriers with cutting-edge solutions designed to accelerate clinical impact. 📅 Join our live webinar on March 20 at 12 PM EST to explore: ✅ High-Efficiency #mRNA_LNP iPSC Reprogramming Cocktail – Streamlining iPSC reprogramming with enhanced efficiency. ✅ GMP #iPSC Line Banks – Fully characterized lines with drug master files to speed up allogeneic therapy development. ✅ Comprehensive #GMP iPSC Platform – Integrated solutions for reprogramming, engineering, banking, and manufacturing. Don’t miss this opportunity to gain insights from industry experts and discover how uBriGene’s solutions can fast-track iPSC-based therapeutic development. 🔗 Register now! via https://lnkd.in/g-6JcqgN
uBriGene Biosciences Inc.
Biotechnology
Richmond, British Columbia 2,138 followers
Your bridge from ATMPs concept to commercialization
About us
uBriGene Biosciences is your bridge from ATMPs concept to commercialization. Our CDMO+ services include cell therapy products (CAR-T, TCR-T, NK Cells, iPSC, Dendritic cells, Macrophages), viral vectors (AAV, LVV, RVV, AdV, oncolytic viruses), plasmids, and RNA (mRNA, circRNA, acRNA). Our extensive experience in manufacturing, QC testing, and regulatory filing support of ATMPs, from early discovery to commercialization, will accelerate your therapeutic programs from bench to bedside. With four Centers of Excellence in North America, and Asia Pacific and more than 20 GMP clean room suites, uBriGene supports global CGT, vaccine, and RNA product development.
- Website
-
www.ubrigene.com
External link for uBriGene Biosciences Inc.
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Richmond, British Columbia
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Gene and Cell, Car-T, Clinical applications, CRO, CDMO, Plasmids, Viral Vector, Gene editing, mRNA, and Advanced therapy medicinal products
Locations
-
Primary
13351 Commerce Pkwy
1208
Richmond, British Columbia V6V 2X7, CA
Employees at uBriGene Biosciences Inc.
-
Alex Chen
Cell & Gene Therapy CDMO
-
Baker Lu
Cell and Gene Therapy Project Management, Gene and Cell therapy CRO/CDMO products, T cell, iPSC, plasmid DNA, lenti-virus, AAV, Ad, enzymes, reagents
-
Scott Pattison
Builder of Impactful Biotech Strategic Partnerships
-
Qinghua (Jenny) Zhao
Maryland USA
Updates
-
🚀 Spring Promotion – 20% OFF iPSC Reprogramming Cocktail! 🚀 #uBriGene is offering an exclusive 20% discount on our Highly Efficient #iPSC_Reprogramming_Cocktail – a high-quality solution designed to streamline your induced pluripotent stem cell (#iPSC) generation. 🔬 Product Features: #mRNA_based_reprogramming – No risk of gene integration #Ready_to_use_LNP_mix – No need for transfection reagents or viral vectors #Low_cytotoxicity – High reprogramming efficiency #Versatile_system – Works in both feeder and feeder-free conditions Take advantage of this limited-time discount to accelerate your research with a powerful and efficient reprogramming solution. Check discounted product list via https://lnkd.in/gNxCc7CT Visit https://lnkd.in/gi7D6CvC for more information about promotion terms and conditions
-
-
Do you need #in_stock_LVV_packaging_plasmids? uBriGene's LVV packaging plasmids have been proven to support high infectious LVV production. 🚀DMF files with the #FDA 🚀R&D and #GMP_grade_LVV_packaging_plasmids 🚀Support high-yield #LVV_production 🚀Loyalty-free from #uBriGene Contact us for a quote! Via https://lnkd.in/gE29p_BB
-
-
🔬 Advancing Oncolytic Virus Therapy Manufacturing Oncolytic virus therapy is transforming cancer treatment by using genetically modified viruses to selectively target and destroy cancer cells while sparing healthy ones. These viruses not only attack tumors directly but also activate the immune system for a powerful anti-cancer response. #uBriGene specializes in the #GMP_production of #adenovirus, #herpes_simplex_virus, and #vaccinia_virus, supporting the development of cutting-edge immunotherapies. With over 10 successful GMP batches of vaccinia virus, we ensure high-quality, scalable manufacturing with a 30% GMP yield and a 1-month MVB preparation timeline. 🚀 Reliable. Scalable. Experienced. Partner with us to accelerate the future of oncolytic virus therapies. 🔗 Learn more: https://lnkd.in/gsFic3Ym
-
-
🚀 Transforming mRNA & Plasmid Quality Testing in a Rapidly Evolving Landscape 🚀 #uBriGene understands the challenges of ensuring top-quality #mRNA and #plasmid products—especially in today’s rapidly evolving landscape. Our comprehensive analytical development and testing services are designed to meet the highest regulatory standards, helping you navigate the complexities of product characterization and release with ease. With over 300 GMP batches released and a dedicated team offering custom method development, validation, and tech transfer, uBriGene supports your innovation journey every step of the way. Learn more about our services via https://lnkd.in/gWt69cks
-
-
🚀 Boost Your iPSC Research with #uBriGene’s iPSC Reprogramming Cocktail! Skip the complexity—our ready-to-use, #mRNA_LNP_iPSC Reprogramming Cocktail delivers efficient, non-integrating reprogramming with low toxicity and high yield. No viral vectors, no extra reagents—just seamless iPSC generation. 🔹Safe, mRNA-based reprogramming 🔹Simple, direct-to-cell application 🔹Works in feeder & feeder-free systems Let’s advance your iPSC and regenerative medicine breakthroughs! Connect with our expert to learn more: https://lnkd.in/g3eXv7VH
-
-
Take your #Cell_Therapy to the next level with uBriGene 's comprehensive CDMO platform. From concept to clinic, we deliver end-to-end solutions tailored to your needs. 🔬 Accelerated IND Pace: Our streamlined processes, regulatory expertise, and efficient logistics enable rapid and reliable #IND_filings to keep your projects on track. 🧬 Cutting-Edge Gene Modification: Leverage advanced platforms like #CRISPR and #lentivirus to maintain therapy integrity, potency, and unmatched quality. 🏭 Streamlined Production: With fully closed systems and rigorous controls, we ensure therapy integrity and regulatory compliance every step of the way. ⭐ Proven Expertise in #CAR_T & #CAR_NK Manufacturing: With over 100 GMP CAR-T batches delivered and extensive IND filing experience, we bring reliability and excellence to your cell therapy journey. Let’s turn your vision into reality! Partner with #uBriGene_Biosciences to advance your cell therapy. 📩 Contact us https://lnkd.in/g3eXv7VH today to get started!
-
-
🧬Accelerate Your Research with #uBriGene! Looking for reliable #iPSC_reprogramming or #CRISPR tools? We’re here to help: ✨ mRNA-LNP reprogramming mix for iPSC generation, available in research & #GMP_grades to fit your needs. 🛠️GMP grade Cas9 nuclease, Cas9 #mRNA, #sgRNA, #ssDNA, and linear closed end #dsDNA manufacturing. ✅Plus, our full-service #CRISPR_gene_editing supports your projects from start to finish. 💡 Contact our experts https://lnkd.in/g3eXv7VH and take your innovations to the next level!
-
-
🌟 uBriGene at JPM 2025 🌟 #uBriGene will be participating in the J.P. Morgan Healthcare Conference 2025 from January 13-16 in San Francisco, CA. Our team will be on-site, ready to showcase our cutting-edge solutions in #cell_and_gene_therapy, discuss partnership opportunities, and explore how we can accelerate innovation together. 📍 Attending #JPM2025? Reach out to schedule a meeting with our team.
-
-
uBriGene Biosciences team wishes you a joyful holiday season and a prosperous New Year! 🎄✨ As we reflect on 2024, we're grateful for the incredible partnerships and growth we've experienced. Here's to an exciting and successful 2025 ahead! Wishing you all happiness, health, and new opportunities in the year to come.
-